SCHEMBL25359331

SCHEMBL25359331

CC12CC3CC1C2C3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14040661 0.84
SCHEMBL14287476 0.79
SCHEMBL14040607 0.79 GRIN1 (0.37)
SCHEMBL13991089 0.74
SCHEMBL13990989 0.74 GRIN2D (0.43)
SCHEMBL4959783 0.69 GRIN2D (0.38)
SCHEMBL7194747 0.69 GAA (0.33)
SCHEMBL14287480 0.69 LMNA (0.42)
SCHEMBL14287492 0.69
SCHEMBL14051193 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129033-A1 METAP2 INHIBITORS AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2025-04-24 US disclosed
EP-4479133-A1 METAP2 INHIBITORS AND USES THEREOF Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (IL) 2024-12-25 EP disclosed
WO-2023156996-A1 METAP2 INHIBITORS AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2023-08-24 WO disclosed